Global Capillary Blood Collection Devices Market Report 2024

The capillary blood collection devices market size has grown rapidly in recent years. It will grow from $2.13 billion in 2023 to $2.41 billion in 2024 at a compound annual growth rate (CAGR) of 13%. The growth observed in the historic period can be attributed to several factors, including heightened awareness of disease screening, the upsurge in home healthcare services, the expanding geriatric demographic, a heightened focus on preventive medicine, and the broadening scope of infectious disease testing.

The capillary blood collection devices market size is expected to see rapid growth in the next few years. It will grow to $3.97 billion in 2028 at a compound annual growth rate (CAGR) of 13.3%. The anticipated growth in the forecast period can be linked to several factors, including a growing preference for point-of-care testing, the escalating incidence of chronic diseases, a surge in demand for remote patient monitoring services, an increasing emphasis on preventive healthcare measures, and heightened awareness regarding infectious diseases. Noteworthy trends expected in this period encompass point-of-care testing, continuous technological advancements, the integration of microfluidics, the expansion of personalized medicine approaches, and the adoption of remote patient monitoring solutions.

The growth of the capillary blood collection devices market is expected to be fueled by the increasing prevalence of chronic diseases. Chronic diseases are long-term health conditions that require ongoing management and treatment. Several factors contribute to the rising prevalence of chronic diseases, such as aging populations, unhealthy lifestyles, environmental influences, and advancements in medical diagnostics leading to improved disease detection. Capillary blood collection devices play a crucial role in enabling patients and healthcare providers to manage chronic diseases more effectively by facilitating regular, convenient, and less invasive blood testing. This ultimately results in better patient outcomes and improved quality of life. For instance, according to the International Diabetes Federation in July 2021, the number of adults with diabetes was 537 million, projected to reach 783 million by 2045. Hence, the growing prevalence of chronic diseases is a key driver for the expansion of the capillary blood collection devices market.

Major players in the capillary blood collection devices market are concentrating on developing innovative products tailored to specific needs and challenges in healthcare settings, particularly for infants and young children. For example, in October 2023, Owen Mumford Ltd. introduced Unistik Heelstik, a range of capillary blood sampling devices designed for neonates and children. This range includes four instruments, each suited for a specific developmental stage, Unistik Heelstik Toddler, Full Term, Preemie, and Micro Preemie. These devices aim to address the challenges of capillary blood sampling in newborns and older babies, ensuring acceptable sample volumes while minimizing discomfort for the baby. The Unistik Heelstik devices target only surface blood vessels, avoiding penetration deep enough to stimulate skin pain fibers.

In May 2022, Babson Diagnostics Inc., a US-based healthcare company, partnered with Becton, Dickinson, and Company. This collaboration aims to innovate and enhance diagnostic blood collection methods, particularly in novel care settings. Becton, Dickinson, and Company is a US-based medical technology firm that manufactures various medical devices, including capillary blood collection devices.

Major companies operating in the capillary blood collection devices market are Cardinal Health Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Danaher Corporation, Novo Nordisk A/S, Becton Dickinson and Company, Henry Schein Inc., Terumo Medical Corporation, Smiths Medical ASD Inc., QIAGEN N.V., Gerresheimer AG, Radiometer America Inc., Greiner Bio-One International GmbH, SARSTEDT AG & Co. KG, Natus Medical Incorporated, Ypsomed Holding AG, Nipro Europe N.V., SEKISUI Medical Co. Ltd., Owen Mumford Ltd., PTS Diagnostics, Narang Medical Limited, Drew Scientific Group, B. Braun Lanka (Pvt) Ltd, HTL-STREFA S.A., Chengdu Rich Science Industry Co. Ltd.

North America was the largest region in the capillary blood collection devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the capillary blood collection devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the capillary blood collection devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Capillary blood collection devices refer to medical instruments utilized for acquiring small blood samples via a minimally invasive method, typically from areas such as the fingertip, heel, or earlobe. These tools are engineered to puncture the skin minimally to extract a small quantity of capillary blood, which is then utilized for a range of diagnostic assessments.

The primary components of capillary blood collection devices include lancets, micro-container tubes, micro-hematocrit tubes, warming devices, and other related items. Lancets are small, sharp instruments employed to puncture the skin, extracting a small blood droplet for testing purposes. These devices incorporate a variety of materials such as plastic, glass, stainless steel, ceramic, among others, catering to a wide array of tests such as whole blood analysis, serum protein tests, comprehensive metabolic panel tests, liver function tests, and dried blood spot tests. These devices find utility in hospitals, clinics, blood donation centers, diagnostic facilities, home diagnostics, and pathology laboratories.

The capillary blood collection devices market research report is one of a series of new reports that provides capillary blood collection devices market statistics, including capillary blood collection devices industry global market size, regional shares, competitors with capillary blood collection devices market share, detailed capillary blood collection devices market segments, market trends, and opportunities, and any further data you may need to thrive in the capillary blood collection devices industry. This capillary blood collection devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The capillary blood collection devices market consists of sales of blood transfer devices, blood collection systems, Lancets, micro sampling devices and warming devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.